TCL Archive GAO Investigation Of Cancer Control Focuses On Five Contracts, Finds Alleged Deficiencies July 18, 1980
TCL Archive Was Dr. Bunn Insensitive Or Just Efficient? FDA Imbroglio Points To Larger Problems November 10, 1995
TCL Archive In Brief: DeVita Changes His Mind, Agrees To Head Treatment DIV; Contracts Chief Carl Fretts Moves Up To NIH October 4, 1974
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
